The suit alleges that Reckitt Benckiser Pharmaceuticals, now known as Indivior, conspired with MonoSol Rx to switch the drug Suboxone from a tablet version to a film, similar to a breath strip, in order to delay generic alternatives and maintain monopoly profits. The companies are accused of violating Arkansas and federal antitrust laws.
↧